Core Insights - Bango PLC has formed a strategic partnership with KT, a leading telecommunications provider in South Korea, to deliver subscription services to KT's 13.5 million customers, marking Bango's first major DVM agreement in Korea [1][2] - The partnership aims to integrate a variety of third-party services, including AI and language subscriptions, into KT's subscription hub, addressing the growing consumer demand for advanced digital experiences [2][3] - KT is at the forefront of AI solution development in South Korea and is expanding its offerings to include innovative AI services that enhance productivity and creativity through Bango's Digital Vending Machine (DVM) [3][4] Company and Industry Developments - The Bango DVM simplifies subscription bundling, transforming a complex operational challenge into a scalable business model, allowing KT to quickly deploy new offers and gain insights for personalized service [4][5] - KT's collaboration with Bango is seen as a pivotal moment for its subscription platform, enabling it to evolve into a global subscription service hub and meet the changing needs of users [5] - Bango's technology is trusted by major content providers like Amazon, Google, and Microsoft, positioning it as a key player in the rapidly growing subscription economy [6]

-We have made significant investments to strengthen the business fundament over the past years to be able to realise ambitious profitable growth plans without major additional capital expenditure. We are committed to delivering long-term value to our shareholder both through share price gains and competitive direct returns, and with a healthy financial position, capital-light growth and improved free cash flow we expect to see significantly increased dividend capacity over the years to come, says CFO Ronny ...

PayPoint PlcResults for the year ended 31 March 2025 Further progress towards £100m EBITDA by end of FY26 New targets established for the Group for the next three years, including share buyback programme increased and extended to at least £30 million per annum till the end of FY28 GROUP FINANCIAL HIGHLIGHTS Underlying EBITDA1 of £90.0 million (FY24: £81.3 million) increased by £8.7 million (10.7%)Underlying profit before tax2 of £68.0 million (FY24: £61.7 million) increased by £6.3 million (10.2%)Net corpor ...

First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a Phase 3 clinical study of its single-dose, virus-like particle (VLP) chikungunya vaccine, CHIKV VLP in children 2 to 11 years of age. This first trial of CHIKV VLP in a pediatric population aims to expand the target population for the vaccine, currently approved for persons 12 years of age and ...

12 June 2025 Vast Resources plc ("Vast" or the "Company") Operational Update Vast Resources plc, the AIM quoted mining company, is pleased to announce that it has established a group technical services function including the input of experienced mining engineers, geologists and operations management which will be tasked with undertaking a review of Vast's existing asset base. The focus will be to establish a sustainable operational plan that will subsequently support ongoing technical studies aimed at unloc ...

It is estimated that approximately 10-20 people per million worldwide live with PNH. Although PNH can develop at any age, it is often diagnosed in people between 30-40 years old. In the Phase IIIB APPULSE-PNH study, adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who switched to Fabhalta experienced clinically meaningful improvements in hemoglobin (Hb) levels of 2.01 g/dL on average APPULSE-PNH evaluated Fabhalta in a population with higher baseline hemoglobin (Hb) levels than those enrolled i ...

The grant funding is equivalent to a maximum of 62% of the total Bartles Foundry project cost estimated at approximately £6.8 million for the construction of workshops, stores and offices on the Bartles Foundry site. This will support the requirements associated with South Crofty moving to production and includes the cost for the previously announced purchase of 4.5 acres of land from Cornwall Council (see press release dated April 1, 2025). Conditional planning approval for the development was granted in J ...

On 5 June 2025, the Annual General Meeting of Arco Vara AS adopted the decision to issue a targeted share offering to specific investors in order to increase the company’s share capital.Arco Vara AS announces that the targeted share issue approved by the shareholders has been successfully completed as of 11 June 2025 – the management board has adopted a resolution to shorten the subscription period due to early subscription of issued shares. In accordance with the adopted decision of the general meeting: Th ...

PRESS RELEASE In addition to patent protection, AB8939 is also eligible for regulatory data protection in Canada, preventing generic competition for a period of 8 years following initial approval. AB8939 has also received orphan drug designation for AML from both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). This orphan drug designation provides 10 and 7 years of market exclusivity in Europe and the United States, respectively, after product approval. A separate secondar ...

Utrecht, 12 June 2025 Aalberts announces the successful signing and closing of Note Purchase Agreements for its inaugural debt issuance in the US Private Placement (USPP) market, securing a total equivalent amount of approximately USD 600 million. The transaction comprises approximately USD 500 million and EUR 100 million in Senior Notes, with maturities ranging from 5 to 12 years. Funding has been completed early June. This landmark issuance earmarks a significant milestone in the further optimisation of A ...